
Acrivon Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Peter Blume-Jensen, with a market cap of $79.8M. As of Q3 2025, 56% of shares are held by 45 institutional investors, with RA CAPITAL MANAGEMENT, LLC as the largest holder at 26.52%.
Overview of institutional ownership in ACRV as of Q3 2025 with a market cap of $56.9M
Based on market cap of $56.9M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in ACRV as of Q3 2025
| Institution | Position Value |
|---|---|
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | $15.1M 0.19% of portfolio |
Sands Capital Ventures, LLC Venture Capital | $3.8M 0.84% of portfolio |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | $2.8M 0.00% of portfolio |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $1.6M 0.00% of portfolio |
UBS Group AG Institution | $1.2M 0.00% of portfolio |
VANGUARD GROUP INC Institution | $1.1M 0.00% of portfolio |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | $1.1M 0.00% of portfolio |
A ACORN CAPITAL ADVISORS, LLC Venture Capital | $733.5K 0.37% of portfolio |
B BlackRock, Inc. Institution | $599.0K 0.00% of portfolio |
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | $577.8K 0.00% of portfolio |
Institutional buying and selling activity for ACRV in Q3 2025
| Institution | Net Bought |
|---|---|
UBS Group AG Institution | +$1.2M +682.8K shares |
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | +$249.8K +138.0K shares |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | +$206.5K +114.1K shares |
TWO SIGMA ADVISERS, LLC Hedge Fund•Multi-Strategy | +$188.1K +103.9K shares |
ACADIAN ASSET MANAGEMENT LLC Long Only Manager | +$166.5K +92.0K shares |
ALGERT COLDIRON INVESTORS LLC Hedge Fund•Quant | +$80.8K +44.6K shares |
VANGUARD GROUP INC Institution | +$59.6K +32.9K shares |
GEODE CAPITAL MANAGEMENT LLC ETF Provider | +$50.1K +27.7K shares |
A AAFCPAs Wealth Management, LLC RIA/Wealth | +$19.3K +10.7K shares |
R ROYAL BANK OF CANADA Institution | +$1.7K +917.0 shares |
| Institution | Net Sold |
|---|---|
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | −$641.1K −354.2K shares |
JACOBS LEVY EQUITY MANAGEMENT, INC Hedge Fund•Quant | −$454.9K −382.2K shares |
GOLDMAN SACHS GROUP INC Institution | −$217.8K −120.3K shares |
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy | −$200.9K −111.0K shares |
H HRT FINANCIAL LLC Institution | −$173.6K −145.9K shares |
B BlackRock, Inc. Institution | −$138.8K −76.7K shares |
X XTX Topco Ltd Institution | −$127.0K −70.2K shares |
S Squarepoint Ops LLC Hedge Fund•Quant | −$87.4K −48.3K shares |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC Long Only Manager | −$75.7K −63.6K shares |
Marshall Wace LLP Institution | −$57.0K −31.5K shares |
Institutions that initiated new positions or completely exited ACRV in Q3 2025
| Institution | Position Value |
|---|---|
ACADIAN ASSET MANAGEMENT LLC Long Only Manager | $166.5K 92.0K shares |
ALGERT COLDIRON INVESTORS LLC Hedge Fund•Quant | $80.8K 44.6K shares |
E EverSource Wealth Advisors, LLC RIA/Wealth | $675.0 373.0 shares |
| Institution | Previous Position |
|---|---|
JACOBS LEVY EQUITY MANAGEMENT, INC Hedge Fund•Quant | $454.9K 382.2K shares |
H HRT FINANCIAL LLC Institution | $173.6K 145.9K shares |
SCHWAB CHARLES INVESTMENT MANAGEMENT INC Long Only Manager | $75.7K 63.6K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity | $52.2K 43.9K shares |
AQR CAPITAL MANAGEMENT LLC Hedge Fund•Multi-Strategy | $26.5K 22.3K shares |
Q Quadrature Capital Ltd Institution | $26.3K 22.2K shares |
S SG Americas Securities, LLC Institution | $18.2K 15.3K shares |
Q Qube Research & Technologies Ltd Institution | $15.1K 12.7K shares |
G Ground Swell Capital, LLC Hedge Fund•Multi-Strategy | $14.5K 12.2K shares |
True Wealth Design, LLC RIA/Wealth | $210.0 176.0 shares |
Institutions with the largest Call and Put options positions in ACRV as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with ACRV as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
Sands Capital Ventures, LLC Venture Capital | 0.84% $3.8M |
A ACORN CAPITAL ADVISORS, LLC Venture Capital | 0.37% $733.5K |
RA CAPITAL MANAGEMENT, LLC Hedge Fund•Long/Short | 0.19% $15.1M |
A AAFCPAs Wealth Management, LLC RIA/Wealth | 0.01% $19.3K |
X XTX Topco Ltd Institution | 0.00% $65.1K |
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy | 0.00% $2.8M |
RENAISSANCE TECHNOLOGIES LLC Hedge Fund•Quant | 0.00% $1.1M |
ALGERT COLDIRON INVESTORS LLC Hedge Fund•Quant | 0.00% $80.8K |
TWO SIGMA INVESTMENTS LLC Hedge Fund•Multi-Strategy | 0.00% $577.8K |
B BRIDGEWAY CAPITAL MANAGEMENT INC Long Only Manager | 0.00% $41.4K |
Discover hedge funds investing in ACRV

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $2.6B | 24.14% | |
Biotechnology Healthcare | $982.3M | 9.10% | |
Biotechnology Healthcare | $965.4M | 8.94% |
We use cookies for analytics. See our Privacy and Cookie Policy.